146 related articles for article (PubMed ID: 32340525)
1. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway.
Liu G; Song J; Zhao Y; Zhang L; Qin J; Cui Y
J Recept Signal Transduct Res; 2020 Oct; 40(5):471-478. PubMed ID: 32340525
[No Abstract] [Full Text] [Related]
2. An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.
Geng B; Liang M; Qin L; Zhao W; Wang H; Wang L; Pan X; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1458-1469. PubMed ID: 30515965
[TBL] [Abstract][Full Text] [Related]
3. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
[TBL] [Abstract][Full Text] [Related]
4. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
5. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
6. TRIM59 promotes osteosarcoma progression via activation of STAT3.
Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
[TBL] [Abstract][Full Text] [Related]
7. TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway.
Tong X; Mu P; Zhang Y; Zhao J; Wang X
J Cell Physiol; 2020 Nov; 235(11):8236-8245. PubMed ID: 31951023
[TBL] [Abstract][Full Text] [Related]
8. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
10. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
11. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
13. TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis.
Wang F; Wang H; Sun L; Niu C; Xu J
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C392-C401. PubMed ID: 32348176
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Tripartite-59 (TRIM59) Inhibits Cellular Proliferation and Migration in Human Cervical Cancer Cells.
Aierken G; Seyiti A; Alifu M; Kuerban G
Oncol Res; 2017 Mar; 25(3):381-388. PubMed ID: 27662486
[TBL] [Abstract][Full Text] [Related]
15. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
[TBL] [Abstract][Full Text] [Related]
16. [Down-regulation of tripartite motif containing 59 (TRIM59) blocks the NF-κB signaling pathway and inhibits the invasion and migration of nasopharyngeal carcinoma cells].
Wang W; Zhou L; Sun Z; Wu J; Zhao B; Cui Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):419-424. PubMed ID: 35603650
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
[TBL] [Abstract][Full Text] [Related]
18. MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.
Lin ZH; Wang L; Zhang JB; Liu Y; Li XQ; Guo L; Zhang B; Zhu WW; Ye QH
Int J Oncol; 2014 Aug; 45(2):629-40. PubMed ID: 24859810
[TBL] [Abstract][Full Text] [Related]
19. TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.
Tian Y; Guo Y; Zhu P; Zhang D; Liu S; Tang M; Wang Y; Jin Z; Li D; Yan D; Li G; Zhu X
Aging (Albany NY); 2019 Oct; 11(19):8623-8641. PubMed ID: 31600735
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer.
Xu F; Zhang J
Biomed Pharmacother; 2017 Jun; 90():888-896. PubMed ID: 28441714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
